Literature DB >> 15252269

Clozapine treatment in oromandibular dystonia.

Hasmet A Hanagasi1, Basar Bilgic, Hakan Gurvit, Murat Emre.   

Abstract

Oromandibular dystonia (OMD) is a form of focal dystonias, which can be associated with substantial disability and is frequently refractory to all antidystonic therapies. Clozapine is a dibenzodiazepin derivative atypical neuroleptic that has been reported to be effective in the treatment of primary or symptomatic dystonia. We report here two patients with severe OMD refractory to other antidystonic therapies, who had substantial improvement with clozapine. We suggest that clozapine should be considered in patients with OMD who fail to response to other treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252269     DOI: 10.1097/00002826-200403000-00007

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  5 in total

Review 1.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

2.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

3.  Cortical Silent Period Reveals Differences Between Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia.

Authors:  Sharyl Samargia; Rebekah Schmidt; Teresa Jacobson Kimberley
Journal:  Neurorehabil Neural Repair       Date:  2015-06-18       Impact factor: 3.919

Review 4.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

5.  Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?

Authors:  Ahmed Naguy; Saxby Pridmore; Anubhuti Singh; Bibi Alamiri
Journal:  Psychopharmacol Bull       Date:  2022-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.